RT

Reenu Tiwari

Director Director DIN 06431779
DIN 06431779 First appointment Feb 2015 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Feb 2015
Shareholding value β€’β€’β€’β€’ Premium profile

About Reenu Tiwari

Data last updated:

Reenu Tiwari was a Director at Vanguard Diagnostics Private Limited (2015) and Director at Ocimum Biotech Private Limited (from 2016). The companies operate in Pharma.

DIN 06431779
Primary Designation Director
Industry Pharma
First Appointment 02 Feb 2015
Oldest Company Age 17 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Vanguard Diagnostics Private Limited U33110DL2015PTC276193
Director02 Feb 20152015₹20.87 Cr (FY 2025)Active
Ocimum Biotech Private Limited U93000DL2009PTC193005
Director11 Jul 20162009₹5.4 Lakh (FY 2015)Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Ocimum Biotech Private Limited
Vanguard Diagnostics Private Limited
Premium access

Shareholding and investment profile for Reenu Tiwari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Reenu Tiwari

Reenu Tiwari was first appointed on 02 Feb 2015 as Director at Vanguard Diagnostics Private Limited. The most recent appointment on record is 11 Jul 2016 at Ocimum Biotech Private Limited.

Reenu Tiwari held 2 earlier board appointments: Vanguard Diagnostics Private Limited (Director, 02 Feb 2015 to 26 May 2015); Ocimum Biotech Private Limited (Director, from 11 Jul 2016).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available